Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan
As the largest pharmaceutical company in Japan and a leader in the global industry, Takeda’s mission is to strive toward better health for patients worldwide through leading innovation in medicine. Takeda has a commercial presence covering more than 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China. Takeda’s pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).
Takeda is ranked 12th by global prescription sales, 14th in the BRIC countries (Brazil, Russia, India and China) and 18th in Europe.
Takeda's commercial presence mainly covers the therapeutic areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management.
Takeda's net sales by region (Fiscal 2014)
- Japan: 733.9 billion yen
- North America: 3374.5 billion yen
- Latin America: 81.2 billion yen
- Europe: 297.5 billion yen
- Russia/CIS: 89.6 billion yen
- Asia: 85.4 billion yen
- Others: 29.5 billion yen
Additional information about Takeda is available through its corporate website , www.takeda.com.
TUK120831(1) Date of Preparation May 2015